Results

Total Results: 7,336 records

Showing results for "consideration".

1. Recommendation #8: Naloxone Consideration | CDS Connect
   cds.ahrq.gov/cdsconnect/artifact/recommendation-8-naloxone-consideration
   September 27, 2018 - Search All AHRQ Sites Careers Contact Us Español FAQs Email Updates

2. USPSTF and Cost Considerations (pdf file)
   www.uspreventiveservicestaskforce.org/uspstf/sites/default/files/2025-06/USPSTF-cost-considerations-2025-update.pdf
   January 01, 2025 - The Task Force recognizes that cost is a consideration for insurers, health systems, purchasers, and

3. USPSTF and Cost Considerations (pdf file)
   www.uspreventiveservicestaskforce.org/uspstf/sites/default/files/inline-files/uspstf-cost-considerations-fact-sheet-2021.pdf
   January 01, 2021 - The Task Force recognizes that cost is a consideration for insurers, health systems, purchasers, and

4. USPSTF and Cost Considerations (pdf file)
   www.uspreventiveservicestaskforce.org/uspstf/sites/default/files/inline-files/uspstf-cost-considerations-fact-sheet-2021_0.pdf
   January 01, 2021 - The Task Force recognizes that cost is a consideration for insurers, health systems, purchasers, and

5. Recommendations to Improve Children's Health Care Quality Measures | Agency for Healthcare Research and Quality
   www.ahrq.gov/policymakers/chipra/pubs/background-2012/backgrndtab1.html
   December 01, 2012 - measure topic important to improving care for a condition that is highly prevalent) by taking into consideration … the Early Periodic Screening, Diagnosis, and Treatment (EPSDT) benefit in Medicaid) by taking into consideration … the Measure Please score research evidence for the underlying focus of the measure by taking into consideration … by taking into consideration the information in CPCF Section VI.B. 6 Section VII: Identification … measure to help providers and consumers understand the quality of care for children by taking into consideration

6. Overriding Considerations | PSNet
   psnet.ahrq.gov/web-mm/overriding-considerations
   March 09, 2009 - Overriding Considerations Citation Text: Holtzman NA. Overriding Considerations. PSNet [internet]. Rockville (MD): Agency for Healthcare Research and Quality, US Department of Health and Human Services. 2004. Copy Citation Format: Google Scholar BibTeX EndNote X3 XML EndNote 7 XML Endnote tagg…

7. Staffing Considerations Post-Vaccine | Agency for Healthcare Research and Quality
   www.ahrq.gov/nursing-home/resources/staffing-considerations.html
   August 01, 2022 - Staffing Considerations Post-Vaccine This document provides guidance that builds upon CDC's post-vaccine consideration

8. Safety considerations for IMRT. | PSNet
   psnet.ahrq.gov/issue/safety-considerations-imrt
   March 17, 2021 - Organizational Policy/Guidelines Safety considerations for IMRT. Citation Text: Safety considerations for IMRT. Moran JM, Dempsey M, Eisbruch A, et al. Pract Radiat Oncol. 2011;1(suppl 1):1-33.   Copy Citation Save Save to your library Print D…

9. Funding Award Process at AHRQ | Agency for Healthcare Research and Quality
   www.ahrq.gov/funding/process/award-process/index.html
   June 01, 2017 - Several factors are taken into consideration, including: Reviewers' priority or percentile score … After careful review, an application may be presented for funding consideration along with other applications

10. Labor and Delivery Unit Safety: Facilitator Guide | Agency for Healthcare Research and Quality
    www.ahrq.gov/patient-safety/settings/labor-delivery/perinatal-care/modules/strategies/labor-delivery-unit/ldusafety-fac-guide.html
    July 01, 2023 - Slide 9: Key Safety Elements: Standardize When Possible Say: The first consideration of L&D unit … Slide 12: Key Safety Elements: Create Independent Checks Say: The second consideration of L&D … Slide 14: Key Safety Elements: Simulation Say: The next consideration of L&D unit safety for safe … Slide 17: Key Safety Elements: Create Independent Checks Say: The next consideration of L&D unit … Slide 24: Key Safety Elements: Simulation Say: The next consideration is simulation .

11. Safe Medication Administration: Facilitator Guide | Agency for Healthcare Research and Quality
    www.ahrq.gov/patient-safety/settings/labor-delivery/perinatal-care/modules/strategies/medication/safe-medication-fac-guide.html
    July 01, 2023 - Slide 9: Key Safety Elements: Standardize When Possible Say: The first consideration for Safe … Slide 10: Key Safety Elements: Create Independent Checks Say: The second consideration for Safe … Slide 16: Key Safety Elements: Patient and Family Engagement Say: The sixth consideration for … Slide 20: Key Safety Elements: Standardize When Possible Say: The first consideration for Safe … Slide 27: Key Safety Elements: Patient and Family Engagement Say: The sixth consideration for

12. Ldusafety Facguide (doc file)
    www.ahrq.gov/sites/default/files/wysiwyg/professionals/quality-patient-safety/hais/tools/perinatal-care/modules/strategies/labor-delivery-unit/ldusafety_facguide.docx
    May 01, 2017 - Slide 11 SAY: The second consideration of L&D unit safety for safe cesarean section is to create … Slide 13 SAY: The next consideration of L&D unit safety for safe cesarean section is simulation. … Slide 15 SAY: The first consideration of L&D unit safety for management of shoulder dystocia is to … Slide 31 SAY: The fifth consideration is teamwork training. … Slide 32 SAY: The final consideration is patient and family engagement.

13. Safemed Facguide (doc file)
    www.ahrq.gov/sites/default/files/wysiwyg/professionals/quality-patient-safety/hais/tools/perinatal-care/modules/strategies/medication/safemed_facguide.docx
    May 01, 2017 - Slide 9 (continued) SAY: The second consideration for Safe Medication Administration of Oxytocin … Slide 10 (continued) SAY: The third consideration for Safe Medication Administration of Oxytocin is … Slide 11 SAY: The fourth consideration for Safe Medication Administration of Oxytocin is simulation … Slide 23 SAY: The third consideration of Safe Medication Administration of magnesium is learn from … Slide 24 SAY: The fourth consideration for Safe Medication Administration of Magnesium Sulfate is

14. Four Key Strategies To Prevent MRSA & SSI (pdf file)
    www.ahrq.gov/sites/default/files/wysiwyg/hai/tools/mrsa-2/120-key-strategies-target-mrsa-ssi.pdf
    April 01, 2025 - Glycemic control  Normothermia  Operating room traffic • Antimicrobial prophylaxis is a crucial consideration … • An important consideration is the correct use of intravenous vancomycin for patients confirmed

15. Preserving organizational resilience, patient safety, and staff retention during COVID-19 requires a holistic consideration of the psychological safety of healthcare workers | PSNet
    psnet.ahrq.gov/issue/preserving-organizational-resilience-patient-safety-and-staff-retention-during-covid-19
    May 08, 2019 - organizational resilience, patient safety, and staff retention during COVID-19 requires a holistic consideration … organizational resilience, patient safety, and staff retention during COVID-19 requires a holistic consideration … organizational resilience, patient safety, and staff retention during COVID-19 requires a holistic consideration

16. Measure 1, Section 14, Attachment 1 (pdf file)
    www.ahrq.gov/sites/default/files/wysiwyg/policymakers/chipra/factsheets/fullreports/chipra-88-measure-1-section-14-attachment-1.pdf
    January 01, 2011 - DRAFT MEASURES for Work Group consideration – Please do not cite or distribute 1 … DRAFT MEASURES for Work Group consideration – Please do not cite or distribute 2 Table of Contents … DRAFT MEASURES for Work Group consideration – Please do not cite or distribute 3 Work Group Members … DRAFT MEASURES for Work Group consideration – Please do not cite or distribute 4 Executive Summary … DRAFT MEASURES for Work Group consideration – Please do not cite or distribute 7 CPT®

17. ADHD Performance Measurement Set (pdf file)
    www.ahrq.gov/sites/default/files/wysiwyg/policymakers/chipra/factsheets/fullreports/chipra-89-adhd-behavior-section-14-attach-1.pdf
    January 01, 2011 - DRAFT MEASURES for Work Group consideration – Please do not cite or distribute 1 … DRAFT MEASURES for Work Group consideration – Please do not cite or distribute 2 . … DRAFT MEASURES for Work Group consideration – Please do not cite or distribute 3 Work Group Members … DRAFT MEASURES for Work Group consideration – Please do not cite or distribute 9 ability to pay … DRAFT MEASURES for Work Group consideration – Please do not cite or distribute 10 coverage, and

18. Measure 1, Section 2, Attachment 1 (pdf file)
    www.ahrq.gov/sites/default/files/wysiwyg/policymakers/chipra/factsheets/fullreports/chipra-88-measure-1-section-2-attachment-1.pdf
    February 01, 2012 - DRAFT MEASURES for Work Group consideration – Please do not cite or distribute 1 … DRAFT MEASURES for Work Group consideration – Please do not cite or distribute 2 . … DRAFT MEASURES for Work Group consideration – Please do not cite or distribute 9 The method was … DRAFT MEASURES for Work Group consideration – Please do not cite or distribute 10 populations, … DRAFT MEASURES for Work Group consideration – Please do not cite or distribute 14 DRAFT Measure

19. Labor and Delivery Unit Safety (pdf file)
    www.ahrq.gov/sites/default/files/wysiwyg/professionals/quality-patient-safety/hais/tools/perinatal-care/modules/strategies/labor-delivery-unit/ldusafety_facguide.pdf
    May 01, 2017 - Delivery Unit Safety AHRQ Safety Program for Perinatal Care L&D Unit Safety 5 SAY: The first consideration … Delivery Unit Safety AHRQ Safety Program for Perinatal Care L&D Unit Safety 8 SAY: The next consideration … Delivery Unit Safety AHRQ Safety Program for Perinatal Care L&D Unit Safety 9 SAY: The first consideration … SAY: The next consideration of L&D unit safety for postpartum hemorrhage management is to create independent … Slide 25 SAY: The first consideration of L&D unit safety for cord prolapse management is to standardize

20. Attention Deficit Hyperactivity Disorder Performance Measurement Set (pdf file)
    www.ahrq.gov/sites/default/files/wysiwyg/policymakers/chipra/factsheets/fullreports/chipra-89-adhd-behavior-section-2-attach-1.pdf
    February 01, 2012 - DRAFT MEASURES for Work Group consideration—Please do not cite or distribute 1 … DRAFT MEASURES for Work Group consideration—Please do not cite or distribute 2 Table of Contents … DRAFT MEASURES for Work Group consideration—Please do not cite or distribute 3 Work Group Members … DRAFT MEASURES for Work Group consideration—Please do not cite or distribute 4 Executive Summary … DRAFT MEASURES for Work Group consideration—Please do not cite or distribute 5 The aforementioned